Ongoal Technology
301662
Rastar Group
300043
Senba Sensing Technology
300701
4
Beijing DeepGlint Technology
688207
5
Shenzhen Chuangyitong Technology
300991
US Stock MarketDetailed Quotes
AMPH Amphastar Pharmaceuticals
- 22.990
- -0.510-2.17%
Close Apr 16 16:00 ET
- 24.120
- +1.130+4.92%
Post 20:01 ET
1.09BMarket Cap7.51P/E (TTM)
23.743High22.640Low904.63KVolume23.620Open23.500Pre Close20.91MTurnover2.48%Turnover Ratio7.51P/E (Static)47.50MShares53.95552wk High1.49P/B840.29MFloat Cap22.64052wk Low--Dividend TTM36.55MShs Float67.660Historical High--Div YieldTTM4.69%Amplitude6.670Historical Low23.110Avg Price1Lot Size
Amphastar Pharmaceuticals Key Stats
EPS
According to the latest financial report of Amphastar Pharmaceuticals, the latest earnings per share (TTM) for the company is 0.74. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Amphastar Pharmaceuticals's free cash flow? The latest report shows it as 16.61M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Amphastar Pharmaceuticals shows that the company's current ratio is 3.07, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Amphastar Pharmaceuticals, the quick ratio is 2.07, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Amphastar Pharmaceuticals? The latest ROE figure is 5.20%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Amphastar Pharmaceuticals, the total asset return on investment (ROA) is 2.43%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Amphastar Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 46.45%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Amphastar Pharmaceuticals, the net profit margin is 20.35%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025